Lhasa and Optibrium improve predictive modelling for drug-metabolising enzymes
Research shows how novel predictive models develop drug design and reduce toxicity
Read More
Tag: optibrium
AI drug discovery platform gets £1m innovation boost
Innovate UK is streaming funds into a £1-million artificial intelligence (AI) research project to be delivered by the Medicines Discovery Catapult and two Cambridge-based firms with expertise in software/machine learning.
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
